Cheniaux Elie, Landeira-Fernandez J, Lessa Telles Leonardo, Lessa José Luiz M, Dias Allan, Duncan Teresa, Versiani Marcio
Institute of Psychiatry of Federal University of Rio de Janeiro, Brazil.
J Affect Disord. 2008 Mar;106(3):209-17. doi: 10.1016/j.jad.2007.07.009. Epub 2007 Aug 23.
Since its first definition in the literature, schizoaffective disorder (SAD) has raised a considerable controversy regarding its clinical distinction from schizophrenia (SCH) and mood disorders (MD) as well as its validity as an independent nosological category.
Investigate the validity of SAD as a discrete nosological category and its relationship with SCH and MD.
A systematic literature review of clinical trial that compared SAD with SCH and/or MD patients was carried out throughout MEDLINE, psycINFO, Cochrane Library, SCIELO and LILACS databases.
Evaluation of demographic characteristics, symptomatology, other clinical data, dexamethasone suppression test, neuroimage exams, response to treatment, evolution and family morbidity indicated that SAD occupies an intermediate position between SCH and MD. Literature review also failed to indicate a clear cut distinction between SAD and SCH or MD.
Present analysis indicated that SAD cannot be interpreted as atypical forms of SCH or MD. SAD also does not appear to represent a SCH and MD comorbidity or yet an independent mental disorder. It is argued that SAD might constitute a heterogeneous group composed by both SCH and MD patients or a middle point of a continuum between SCH and MD.
自精神分裂症伴情感障碍(SAD)在文献中首次被定义以来,关于它与精神分裂症(SCH)和心境障碍(MD)在临床上的区别以及作为一个独立疾病分类范畴的有效性,引发了相当大的争议。
研究SAD作为一个独立疾病分类范畴的有效性及其与SCH和MD的关系。
通过MEDLINE、psycINFO、Cochrane图书馆、科学电子数据库在线(SCIELO)和拉丁美洲及加勒比卫生科学数据库(LILACS)数据库,对比较SAD与SCH和/或MD患者的临床试验进行系统的文献综述。
对人口统计学特征、症状学、其他临床数据、地塞米松抑制试验、神经影像检查、治疗反应、病情演变和家族发病率的评估表明,SAD处于SCH和MD之间的中间位置。文献综述也未能表明SAD与SCH或MD之间有明确的区别。
目前的分析表明,SAD不能被解释为SCH或MD的非典型形式。SAD似乎也不代表SCH和MD的共病,也不是一种独立的精神障碍。有人认为,SAD可能构成一个由SCH和MD患者组成的异质性群体,或者是SCH和MD之间连续体的一个中间点。